The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland
Stefan Rutkowski(Universität Hamburg), Thomas Perwein(Medical University of Graz), Petra Ketteler(Essen University Hospital), Martin Benesch(St Nicholas Hospital), Christof M. Kramm(Universitätsmedizin Göttingen), Andreas Faldum(University of Münster), Hermann L. Müller(Klinikum Oldenburg), Brigitte Bison(University of Augsburg), Christian Hagel(Universität Hamburg), Matthias Eyrich(University of Würzburg), Gudrun Fleischhack(Essen University Hospital), Lisa Bußenius(Universität Hamburg), Pedram Emami(Universität Hamburg), Monika Warmuth‐Metz, Michael C. Frühwald(University Hospital Augsburg), Astrid Gnekow(University Hospital Augsburg), Till Milde, Barbara von Zezschwitz(Humboldt-Universität zu Berlin), Uwe Kordes(Universität Hamburg), O. Witt(German Cancer Research Center), Cécile M. Ronckers(Johannes Gutenberg University Mainz), Katja Baust(University Hospital Bonn), Holger Ottensmeier(Universitätsklinikum Würzburg), Jürgen Debus(Heidelberg University), Stephan Tippelt(Essen University Hospital), D Sturm(German Cancer Research Center), Stefan Schönberger(Essen University Hospital), Rolf D. Kortmann(Leipzig University of Applied Sciences), Fabian Pöhl(University of Regensburg), Rudolf Schwarz(Universität Hamburg), Carsten Friedrich(Klinikum Oldenburg), Ulrich Schüller(Universität Hamburg), Torsten Pietsch(University of Bonn), Johannes E. A. Wolf(Dr. August Wolff (Germany)), Pablo Hernáiz‐Driever(Humboldt-Universität zu Berlin), Arend Koch(Humboldt-Universität zu Berlin), Mechthild Krause(German Cancer Research Center), Pascal Johann(University Hospital Augsburg), Martin Hasselblatt(University Hospital Münster), Stefan M. Pfister(German Cancer Research Center), David Capper(German Cancer Research Center), Christian Thomas(University Hospital Münster), Desiree Grabow(Johannes Gutenberg University Mainz), David T. W. Jones(German Cancer Research Center), Denise Obrecht‐Sturm(Universität Hamburg), Karoline Nemes(University Hospital Augsburg), Jürgen Krauss(University of Würzburg), Ahmed El Damaty(Heidelberg University), Felix Sahm(German Cancer Research Center), Martin U. Schuhmann(University Children's Hospital Tübingen)
Cited by 1
Related Papers
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
|The Lancet Neurology|2020|1.4k
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
|Journal of Clinical Oncology|2005|654
Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition
|Journal of Biological Chemistry|1993|477